Who
Andrea F. Wainer
Director
Company insider
Files Form 4 as: Director, Neogen; Director, Analog Devices; Retired EVP, Abbott Laboratories.
In numbers
- Trades disclosed
- 102
- Buys
- 0
- Sells
- 23
- Bought
- $0
- Sold
- $25.4M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 3 Jun 2019
- Last trade
- 1 Oct 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 1 Oct 2026filed 2 Oct 2026 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $120K9,804 at $12.24 | filing |
| 1 Oct 2026filed 2 Oct 2026 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —20,558 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | ADI Analog DevicesSemiconductors | SEC FORM 4 Code A | —747 at $0.00 | filing |
| 11 Mar 2026filed 12 Mar 2026 | ADI Analog DevicesSemiconductors | SEC FORM 4 Code A | —747 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —50,814 at $0.00 | filing |
| 23 Oct 2025filed 27 Oct 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $120K19,769 at $6.07 | filing |
| 2 Jun 2025filed 4 Jun 2025 | NEOG Neogenoption or derivative · Diagnostics & Labs | SEC FORM 4 Code A | —16,303 at $0.00 | filing |
| 2 Jun 2025filed 4 Jun 2025 | NEOG NeogenDiagnostics & Labs | SEC FORM 4 Code A | $35K6,090 at $5.69 | filing |
| 12 Mar 2025filed 14 Mar 2025 | ADI Analog DevicesSemiconductors | SEC FORM 4 Code A | —1,160 at $0.00 | filing |
| 3 Mar 2025filed 4 Mar 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $131K949 at $138.17 | filing |
| 28 Feb 2025filed 4 Mar 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $994K7,313 at $135.87 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —45,730 at $0.00 | filing |
| 25 Feb 2025filed 27 Feb 2025 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —12,278 at $0.00 | filing |
| 18 Feb 2025filed 19 Feb 2025 | ADI Analog Devicesoption or derivative · Semiconductors | SEC FORM 4 Code A | —185 at $0.00 | filing |
| 29 Feb 2024filed 4 Mar 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code F | $1.0M8,339 at $120.05 | filing |
| 23 Feb 2024filed 27 Feb 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code M | —12,500 at $0.00 | filing |
| 23 Feb 2024filed 27 Feb 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code M | $749K12,500 at $59.94 | filing |
| 23 Feb 2024filed 27 Feb 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Sold | $1.5M12,500 at $120.00 | filing |
| 21 Feb 2024filed 23 Feb 2024 | ABT Abbott Laboratoriesoption or derivative · Biotechnology | SEC FORM 4 Code A | —51,397 at $0.00 | filing |
| 21 Feb 2024filed 23 Feb 2024 | ABT Abbott LaboratoriesBiotechnology | SEC FORM 4 Code A | —13,677 at $0.00 | filing |
News
Abbott Laboratories announces a baby formula spinoff companyABT · marketplace.org · 21 Oct 2026Abbott anticipates nutrition separation by end of next year and forecasts Q4 adjusted EPS of $1.62-$1.67 (NYSE:ABT)ABT · seekingalpha.com · 21 Oct 2026Abbott Laboratories plans to spin off nutrition businessABT · chicagotribune.com · 21 Oct 2026
0 headlines in the last 90 days name Andrea F. Wainer; 3 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.